Bajaj Finserv invests Rs. 5799.99974 crore by subscribing 5.74 crore warrants in Bajaj Finance
Subscription at Rs. 1,010 per warrant converts into equivalent equity shares under preferential allotment
Bajaj Finserv Limited has subscribed to 5,74,25,740 warrants issued by its subsidiary Bajaj Finance Limited on a preferential basis, investing Rs. 57,999,999,740 at Rs. 1,010 per warrant. Each warrant is convertible into one equity share of Bajaj Finance.
Bajaj Finserv Limited
Acquisition / Amalgamation / Merger / Demerger
On 10 November 2026, Bajaj Finserv Limited subscribed to 5,74,25,740 warrants issued by its subsidiary Bajaj Finance Limited on a preferential basis, committing Rs. 57,999,999,740. Each warrant is convertible into one equity share of Bajaj Finance at an issue price of Rs. 1,010.
This subscription follows the Board of Directors’ approval on 1 October 2026 for a preferential allotment of warrants by Bajaj Finance Limited with an aggregate cash consideration not exceeding Rs. 5,800 crore.
The warrants are issued on a private placement basis and each warrant is convertible into one equity share of Bajaj Finance Limited, thus potentially expanding equity share capital upon conversion.
The transaction signifies Bajaj Finserv’s significant cash infusion into its subsidiary Bajaj Finance Limited via equity-linked instruments under SEBI Listing Regulations.
The investment will be recorded on the books of Bajaj Finserv Limited and disclosed to relevant stock exchanges as per regulatory requirements.
Highlights
- Subscription of 5,74,25,740 warrants by Bajaj Finserv Limited in Bajaj Finance Limited on 10 November 2026.
- Total cash consideration of Rs. 57,999,999,740 at Rs. 1,010 per warrant.
- Warrants convertible into one equity share each, diluting equity upon conversion.
- Transaction conducted under preferential allotment on a private placement basis.
- Board approval for the fundraising was granted on 1 October 2026.
Key Data Snapshot
What happened
- Bajaj Finserv Limited subscribed to 5,74,25,740 warrants issued by Bajaj Finance Limited on 10 November 2026.
- Each warrant is convertible into one equity share at Rs. 1,010 per warrant.
- The total consideration paid by Bajaj Finserv amounts to Rs. 57,999,999,740.
- The subscription was made on a preferential allotment basis, under private placement.
- The Board of Bajaj Finserv approved the transaction on 1 October 2026.
Key details
- Warrants issued by Bajaj Finance Limited, a subsidiary of Bajaj Finserv Limited.
- Subscription executed at an issue price of Rs. 1,010 per warrant.
- The amount subscribed is below the previously approved upper limit of Rs. 5,800 crore.
- Each warrant is convertible into one equity share, strengthening Bajaj Finance's equity base upon conversion.
- Transaction reported to BSE and NSE under SEBI Listing Regulations.
Regulatory and governance context
- The transaction complies with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended.
- Subscription details disclosed to stock exchanges BSE and NSE on 10 November 2026.
- The Board’s prior approval was in line with regulatory requirements for preferential allotments.
- Bajaj Finserv is a listed company bearing BSE code 532978 and NSE code BAJAJFINSV.
Highlights
- Subscription of 5,74,25,740 warrants by Bajaj Finserv Limited in Bajaj Finance Limited on 10 November 2026.
- Total cash consideration of Rs. 57,999,999,740 at Rs. 1,010 per warrant.
- Warrants convertible into one equity share each, diluting equity upon conversion.
- Transaction conducted under preferential allotment on a private placement basis.
- Board approval for the fundraising was granted on 1 October 2026.
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
More News on Acquisition / Amalgamation / Merger / Demerger
View allLatest corporate announcements and market updates in Acquisition / Amalgamation / Merger / Demerger.
Dr. Agarwal’s Health Care Limited Allots Over 1.5 Crore Equity Shares After Merger with Eye Hospital Arm
Dr. Agarwal’s Health Care Limited has issued 1,51,90,373 fully paid equity shares to shareholders of Dr. Agarwal’s Eye Hospital Limited pursuant to their merger, raising its paid-up equity capital to ₹33,22,89,484 comprised of 33,22,89,484 shares of ₹1 each.
Read Full StoryFIH Mauritius Investments Ltd Acquires 3.24% Additional Stake in IIFL Capital Services, Becoming Promoter
FIH Mauritius Investments Ltd acquired 1,20,58,525 equity shares representing 3.24% stake in IIFL Capital Services Limited through an open offer completed on November 18, 2026. This acquisition boosted their total shareholding to 41.28%, making them the promoter of IIFL Capital Services as of November 19, 2026.
Read Full StoryICICI Prudential AMC Secures SEBI Approval to Acquire PMS Business from ICICI Securities
ICICI Prudential Asset Management Company Limited announced receipt of SEBI's approval to acquire the Portfolio Management Services business from ICICI Securities Limited, allowing the progression of the slump sale transaction agreed earlier in 2026.
Read Full Story